PER3通过激活AMPK/mTOR通路来抑制肺腺癌细胞的增殖/迁移
Guanli Yuan1, Yinfeng Liu2, Dawei Wu3
1Department of General Practice, the First Hospital of Qinhuangdao, Qinhuangdao, 050000, Hebei, China.
Scientific reports
|November 25, 2025
概括
周期昼夜调节器3 (PER3) 通过抑制细胞生长和转移,在肺腺癌中起到瘤抑制作用. 它的失调会影响AMPK/mTOR通路,这表明PER3是肺癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 时间生物学 时间生物学
背景情况:
- 循环节律基因失调与癌症风险增加有关.
- 在肺腺癌中,周期昼夜调节器3 (PER3) 的作用尚不完全理解.
研究的目的:
- 研究PER3在肺腺癌发育和进展中的生物功能.
- 阐明涉及AMPK/mTOR途径的潜在分子机制.
主要方法:
- 在肺腺癌组织中评估PER3表达.
- 在肺癌细胞中利用了PER3过度表达和沉默的lentiviral载体.
- 分析了细胞的增殖,迁移和入侵.
- 研究了对AMPK和mTOR酸化的影响.
- 研究了AMPK/mTOR路径调节者的影响.
主要成果:
- 肺腺癌中PER3的表达减少,与晚期相对应.
- 抑制了PER3的过度表达,而PER3沉默促进了癌细胞的增殖,迁移和入侵.
- PER3调节了AMPK和mTOR的酸化.
- PER3对细胞行为的影响部分由AMPK/mTOR途径介导.
结论:
- 在肺腺癌中,PER3 起到抗致癌的作用.
- PER3通过AMPK/mTOR通路调节癌细胞的行为.
- PER3代表了肺腺癌的潜在生物标志物和治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K


